Pazopanib cancer drug. 200mg tablet of the anti-cancer drug pazopanib, marketed under the name Votrient. Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis, the production of new blood vessels. It is used to treat renal cell (kidney) carcinoma and soft tissue sarcoma. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Marazzi, Dr. P. |
Bildgröße: | 5128 px × 3419 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: |
|